Phong Phu Pharmaceutical JSC (HNX:PPP)

Market Cap	170.72B
Revenue (ttm)	134.98B
Net Income (ttm)	15.75B
Shares Out	8.80M
EPS (ttm)	1,776.91
PE Ratio	10.92
Forward PE	n/a
Dividend	1,500.00 (7.73%)
Ex-Dividend Date	Mar 21, 2025

Volume	200
Average Volume	890
Open	19,000
Previous Close	18,100
Day's Range	19,000 - 19,400
52-Week Range	15,700 - 23,100
Beta	0.06
RSI	48.86
Earnings Date	Jan 23, 2026

About HNX:PPP

Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health protection food, that are offered in tablets, film-coated, sugar-coated, soft capsules, granules, powder, and other forms. It offers its products for respiratory, spiritual, anti-inflammatory, anti-allergic, digest, cardiovascular, diabetes, liver function, and osteoarthritis, as well as provides vitamins and minerals. The ...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 212
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PPP

Financial Performance

In 2024, HNX:PPP's revenue was 137.55 billion, a decrease of -9.61% compared to the previous year's 152.17 billion. Earnings were 15.55 billion, a decrease of -14.28%.